These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8809448)

  • 21. [Intraocular inflammations. A diagnostic and therapeutic challenge].
    Pleyer U
    Ophthalmologe; 2005 Apr; 102(4):325-8. PubMed ID: 15744489
    [No Abstract]   [Full Text] [Related]  

  • 22. Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.
    Krause L; Altenburg A; Pleyer U; Köhler AK; Zouboulis CC; Foerster MH
    J Rheumatol; 2008 May; 35(5):896-903. PubMed ID: 18412306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel approaches to Behçet's disease.
    Sakane T; Takeno M
    Expert Opin Investig Drugs; 2000 Sep; 9(9):1993-2005. PubMed ID: 11060788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study.
    Hamuryudan V; Ozyazgan Y; Fresko Y; Mat C; Yurdakul S; Yazici H
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):928-30. PubMed ID: 12455182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behçet's disease--current status.
    Sharir M; Isakov I
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):946-8. PubMed ID: 12455187
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on interferon in Behçet's disease].
    Kato F
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):63-73. PubMed ID: 6404745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.
    Kotter I; Deuter C; Stubiger N; Zierhut M
    J Rheumatol; 2005 Aug; 32(8):1633; author reply 1634. PubMed ID: 16078350
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ocular manifestations of rheumatic diseases. Cooperation between internist/ophthalmologist].
    Tyndall A; Steiger U
    Klin Monbl Augenheilkd; 1993 May; 202(5):352-5. PubMed ID: 8377390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of interferon alpha in Behçet disease: review of the literature.
    Kötter I; Günaydin I; Zierhut M; Stübiger N
    Semin Arthritis Rheum; 2004 Apr; 33(5):320-35. PubMed ID: 15079763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Behcet's disease. Another case presentation].
    Ritzel G
    Nervenarzt; 1974 Sep; 45(9):489-91. PubMed ID: 4437691
    [No Abstract]   [Full Text] [Related]  

  • 32. Low dose and dose escalating therapy of interferon alfa-2a in the treatment of refractory and sight-threatening Behçet's uveitis.
    Onal S; Kazokoglu H; Koç A; Akman M; Bavbek T; Direskeneli H; Yavuz S
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S113-4. PubMed ID: 19796551
    [No Abstract]   [Full Text] [Related]  

  • 33. Potential of Pegylated Interferon Alpha-2a in Behçet Uveitis: A Report of Five Cases.
    Bielefeld P; Devilliers H; Deschasse C; Saadoun D; Sève P; Muselier A; Creuzot-Garcher C; Besancenot JF; Bron AM
    Ocul Immunol Inflamm; 2016 Oct; 24(5):599-602. PubMed ID: 25760915
    [No Abstract]   [Full Text] [Related]  

  • 34. Interferon-beta and adhesion molecules (E-selectin and s-intracellular adhesion molecule-1) are detected in sera from patients with retinal vasculitis and are induced in retinal vascular endothelial cells by Toll-like receptor 3 signalling.
    Lee MT; Hooper LC; Kump L; Hayashi K; Nussenblatt R; Hooks JJ; Detrick B
    Clin Exp Immunol; 2007 Jan; 147(1):71-80. PubMed ID: 17177965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).
    Couzigou P; Pérusat S; Bourlière M; Trimoulet P; Poynard T; Leroy V; Marcellin P; Foucher J; Bronowicki JP; Chêne G;
    J Gastroenterol Hepatol; 2013 Feb; 28(2):329-34. PubMed ID: 23190183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systemic Adamantiades-Behçet's disease: adverse effects of an otherwise successful therapy with interferon-α-2a].
    Karagiannidis I; Zouboulis CC
    Dtsch Med Wochenschr; 2015 Jan; 140(2):112-3. PubMed ID: 25612283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha.
    Calgüneri M; Onat AM; Oztürk MA; Ozçakar L; Ureten K; Akdogan A; Ertenli I; Kiraz S
    Clin Rheumatol; 2005 Feb; 24(1):64-6. PubMed ID: 15517447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a.
    Amberger M; Groll S; Günaydin I; Deuter C; Vonthein R; Kötter I
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S52-7. PubMed ID: 17949552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon therapy for Behçet's disease.
    Alpsoy E; Yilmaz E; Başaran E
    J Am Acad Dermatol; 1994 Oct; 31(4):617-9. PubMed ID: 8089288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathophysiology and new treatment of uveitis].
    Yanai R; Takeda A; Yoshimura T; Sonoda KH
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(2):74-82. PubMed ID: 24835134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.